China approves AstraZeneca’s lung cancer drug

The drug’s use with chemotherapy for adult patients with extensive-stage small cell lung cancer (SCLC) was approved by China’s National Medical Products Administration, the Anglo-Swedish drugmaker said.The drug’s use with chemotherapy for adult patients with extensive-stage small cell lung cancer (SCLC) was approved by China’s National Medical Products Administration, the Anglo-Swedish drugmaker said.Read More

Leave a Reply

Your email address will not be published. Required fields are marked *